Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 4, 2023
Abstract
Background
Classical
monocytes,
pivotal
in
the
innate
immune
response,
wield
considerable
influence
over
cancer
prognosis
and
response
to
immunotherapy.
Our
aim
was
construct
lung
adenocarcinoma
(LUAD)
prognostic
signature
associated
with
monocytes.
Methods
This
study
encompassed
1,822
samples
drawn
from
diverse
public
datasets.
Initially,
we
conducted
an
comprehensive
analysis
of
single-cell
RNA
sequencing
data
obtained
Gene
Expression
Omnibus
(GEO),
identifying
145
marker
genes
specific
classical
monocyte.
Univariate
Cox
regression
Least
Absolute
Shrinkage
Operator
(LASSO)
analyses
were
performed
on
TCGA
training
cohort
a
for
monocyte
genes.
Result
Patients
LUAD
categorized
into
high-
low-risk
groups
based
polygenic
derived
these
The
predictive
capacity
this
robustly
validated
across
distinct
clinical
subgroups
GEO
cohorts.
Notably,
emerged
as
independent
indicator
via
multivariate
analysis.
Low-risk
patients
exhibited
heightened
cell
infiltration,
correlating
inversely
inflammatory
activity
risk
score.
Conversely,
group
demonstrated
amplified
abundance
diversity
T-cell
receptor
(TCR)
repertoires,
higher
Immunophenotype
scores
(IPS),
lower
Tumor
Immune
Dysfunction
Exclusion
(TIDE)
scores.
Significantly,
assessment
three
immunotherapy
cohorts
showcased
superior
immunotherapeutic
among
compared
their
high-risk
counterparts.
Conclusion
In
summary,
our
introduces
novel
rooted
that
proficiently
prognosticates
predicts
patients.
Supplementary
Information:
information
is
uploaded
attached
document.
Cell Death Discovery,
Год журнала:
2025,
Номер
11(1)
Опубликована: Янв. 29, 2025
Abstract
Lung
carcinoma
incidence
and
fatality
rates
remain
among
the
highest
on
a
global
scale.
The
efficacy
of
targeted
therapies
immunotherapies
is
commonly
compromised
by
emergence
drug
resistance
other
factors,
resulting
in
lack
durable
therapeutic
benefits.
Ferroptosis,
distinct
pattern
cell
death
marked
buildup
iron-dependent
lipid
peroxides,
has
been
shown
to
be
novel
potentially
more
effective
treatment
for
lung
carcinoma.
However,
mechanism
regulatory
network
ferroptosis
are
exceptionally
complex,
many
unanswered
questions
remain.
In
addition,
research
diagnosis
cancer
growing
exponentially.
Therefore,
it
necessary
provide
thorough
summary
latest
advancements
field
ferroptosis.
Here,
we
comprehensively
analyze
mechanisms
underlying
preconditions
ferroptosis,
defense
system,
associated
molecular
networks.
potential
strategies
also
highlighted.
Targeting
improves
tumor
enhances
effectiveness
drugs
immunotherapies.
These
findings
may
shed
fresh
light
management
carcinoma,
as
well
development
related
European journal of medical research,
Год журнала:
2025,
Номер
30(1)
Опубликована: Март 3, 2025
Lung
adenocarcinoma
(LUAD)
is
one
of
the
most
common
and
lethal
tumors.
The
identification
diagnostic
prognostic
biomarkers
essential
to
improve
patient
prognosis
treatment
outcomes.
expression
minichromosome
maintenance
complex
component
8
(MCM8)
in
33
cancer
types
was
analyzed
using
Cancer
Genome
Atlas
(TCGA)
Genotype-Tissue
Expression.
Tumor
normal
tissues
LUAD
were
compared
TCGA
data
validated
against
four
datasets
from
Gene
Expression
Omnibus.
MCM8
assessed
by
immunohistochemistry
(IHC)
tissue
microarrays.
value
Receiver
Operating
Characteristic
curve
analysis,
its
significance
determined
Kaplan–Meier
analysis.
CIBERSORT
method
used
examine
immune
infiltration.
association
between
m6A
RNA
methylation,
glycolysis,
ferroptosis
GEPIA
online
tool.
markedly
overexpressed
many
tumors
including
LUAD.
showed
high
accuracy
for
diagnosis
LUAD,
with
an
area
under
0.849
dataset.
overexpression
tumor
confirmed
IHC
shown
be
associated
decreased
overall
survival
disease-specific
survival.
Analysis
cell
infiltration
that
populations
differed
low
groups.
correlated
genes
ferroptosis.
identified
as
a
promising
marker
mechanism
underlying
effect
on
development
response
remains
elucidated.
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Март 7, 2024
Lung
cancer
is
a
highly
prevalent
malignant
tumor
worldwide,
with
high
incidence
and
death
rates.
Recently,
there
has
been
increasing
recognition
of
the
role
ferroptosis,
unique
cell
mechanism,
in
lung
cancer.
This
review
aims
to
summarize
current
research
progress
on
relationship
between
ferroptosis
It
also
provides
comprehensive
analysis
regulatory
processes
various
stages,
including
epigenetics,
transcription,
post-transcription,
translation,
post-translation.
Additionally,
explores
dual
nature
progression,
which
presents
interesting
therapeutic
possibilities.
On
one
hand,
can
promote
escape
immune
surveillance
reduce
efficacy
treatment
early
stages
tumors.
other
it
counter
drug
resistance,
enhance
radiosensitivity,
immunotherapy.
The
article
discusses
combination
strategies
based
mechanism
ferroptosis.
Overall,
this
offers
holistic
perspective
onset,
contribute
future
clinical
interventions
field.
Natural Products and Bioprospecting,
Год журнала:
2024,
Номер
14(1)
Опубликована: Май 23, 2024
Cancer
cells
generally
exhibit
'iron
addiction'
phenotypes,
which
contribute
to
their
vulnerability
ferroptosis
inducers.
Ferroptosis
is
a
newly
discovered
form
of
programmed
cell
death
caused
by
iron-dependent
lipid
peroxidation.
In
the
present
study,
pacidusin
B,
dichapetalin-type
triterpenoid
from
Phyllanthus
acidus
(L.)
Skeels
(Euphorbiaceae),
induces
in
HT1080
human
fibrosarcoma
line.
Cells
treated
with
B
exhibited
morphological
characteristic
'ballooning'
phenotype
ferroptosis.
The
biochemical
hallmarks
were
also
observed
B-treated
cells.
Both
oxidative
stress
and
ER
play
significant
roles
B-induced
activation
PERK-Nrf2-HO-1
signaling
pathway
led
iron
overload,
while
inhibition
GPX4
further
sensitized
cancer
Furthermore,
molecular
docking
study
showed
that
docked
same
pocket
xCT
as
inducer
erastin.
These
results
revealed
exerts
anticancer
effects
via
inducing
ER-mediated
ferroptotic
death.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 18, 2024
Lung
cancer
has
posed
a
significant
challenge
to
global
health,
and
related
study
been
hot
topic
in
oncology.
This
article
focuses
on
metabolic
reprogramming
of
lung
cells,
process
adapt
energy
demands
biosynthetic
needs,
supporting
the
proliferation
development
tumor
cells.
In
this
study,
latest
studies
metabolism
were
reviewed,
including
impact
products
enzymes
occurrence
cancer,
as
well
progress
field
treatment
targeting
relevant
pathways.
provides
some
promising
potential
directions
into
exploring
helps
researchers
better
understand
cancer.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 24, 2025
To
integrate
machine
learning
and
multiomic
data
on
lactylation-related
genes
(LRGs)
for
molecular
typing
prognosis
prediction
in
lung
adenocarcinoma
(LUAD).
LRG
mRNA
long
non-coding
RNA
transcriptomes,
epigenetic
methylation
data,
somatic
mutation
from
The
Cancer
Genome
Atlas
LUAD
cohort
were
analyzed
to
identify
lactylation
cancer
subtypes
(CSs)
using
10
multiomics
ensemble
clustering
techniques.
findings
then
validated
the
GSE31210
GSE13213
cohorts.
A
model
was
developed
identified
hub
LRGs
divide
patients
into
high-
low-risk
groups.
effectiveness
of
this
validated.
We
two
CSs,
which
Nine
LRGs,
namely
HNRNPC,
PPIA,
BZW1,
GAPDH,
H2AFZ,
RAN,
KIF2C,
RACGAP1,
WBP11,
used
construct
model.
In
subsequent
validation,
high-risk
group
included
more
with
stage
T3
+
4,
N1
2
3,
M1,
III
IV
cancer;
higher
recurrence/metastasis
rates;
lower
1,
5
year
overall
survival
rates.
oncogenic
pathway
analysis,
most
mutations
detected
group.
tumor
microenvironment
analysis
illustrated
that
immune
activity
notably
elevated
patients,
indicating
they
might
strongly
respond
immunotherapy
than
patients.
Further,
oncoPredict
revealed
have
increased
sensitivity
chemotherapeutics.
Overall,
we
a
combines
prognosis.
Our
represent
valuable
reference
further
understanding
important
function
modification
pathways
progression.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Фев. 13, 2025
The
mortality
and
therapeutic
failure
in
lung
adenocarcinoma
(LUAD)
are
mainly
resulted
from
the
wide
metastasis
chemotherapy
resistance.
Up
to
now,
accurate
stable
predictive
prognostic
indicator
for
revealing
progress
novel
strategies
of
LUAD
is
infrequent,
nonetheless.
Diversified
programmed
cell
death
(PCD)
has
been
widely
confirmed
that
participated
occurrence
development
various
malignant
tumors,
respectively.
In
this
research,
we
integrated
fourteen
types
PCD,
bulk
multi-omic
data
TCGA-LUAD
other
cohorts
gene
expression
omnibus
(GEO)
clinical
patients
develop
our
analysis.
Consequently,
pivotal
PCD
genes,
especially
CAMP,
CDK5R1,
CTSW,
DAPK2,
GAB2,
GAPDH,
GATA2,
HGF,
MAPT,
NAPSA,
NUPR1,
PIK3CG,
PLA2G3,
SLC7A11,
were
utilized
establish
signature,
namely
index
(CDI).
validation
several
external
indicated
CDI
can
be
regarded
as
a
potential
risk
factor
patients.
Combined
with
common
information,
nomogram
ability
was
constructed.
Besides,
according
tumor
microenvironment
(TME)
sensitivity
some
chemotherapeutic
drugs
further
deeply
explored.
Notably,
verification
functional
experiments
demonstrated
remarkable
correlation
between
unfold
protein
response.
Given
all
above,
signature
predict
prognosis
exploit
precision
PeerJ,
Год журнала:
2025,
Номер
13, С. e18945 - e18945
Опубликована: Фев. 13, 2025
mRNA
expression-based
stemness
index
(mRNAsi)
has
been
used
for
prognostic
assessment
in
various
cancers,
but
its
application
lung
adenocarcinoma
(LUAD)
is
limited,
which
the
focus
of
this
study.
Low
mRNAsi
LUAD
predicted
a
better
prognosis.
Eight
genes
(
GNG7,
EIF5A,
ANLN,
FKBP4,
GAPDH,
GNPNAT1,
E2F7,
CISH
)
associated
with
were
screened
to
establish
risk
model.
The
differentially
expressed
between
high
and
low
groups
mainly
enriched
metabolism,
cell
cycle
functions
pathway.
score
group
had
higher
immune
scores.
Patients
lower
TIDE
scores
immunotherapy
outcomes.
In
addition,
was
effective
assessing
drug
sensitivity
LUAD.
Reverse
transcription-quantitative
polymerase
chain
reaction
(RT-qPCR)
data
showed
that
eight
lines,
knockdown
EIF5A
reduced
invasion
migration
ability
cells.
This
study
designed
model
based
on
mRNAsi-related
predicting
accurately
prognosis
survival
patients,
facilitating
patients
chemotherapy.
Journal of Proteome Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 27, 2025
Difficulties
in
early-stage
diagnosis
are
among
the
factors
contributing
to
high
mortality
of
nonsmall
cell
lung
carcinoma
(NSCLC)
patients.
Unfortunately,
diagnostic
biomarkers
currently
lacking,
limiting
options
clinic.
To
discover
proteins
that
have
potential
for
biomarker
applications,
we
performed
an
in-depth
quantitative
proteomic
analysis
on
a
cohort
Filipino
NSCLC
adenocarcinoma
(LUAD)
Differentially
expressed
(DEPs)
were
obtained
by
using
tandem
mass
tag
(TMT)
labeling
and
spectrometry
(MS)-based
proteomics.
A
total
6240
quantified
identified
with
3155
significantly
upregulated
1248
downregulated.
Integration
result
curated
transcriptome
data
allowed
identification
33
potential.
This
study
also
provided
insights
into
relevant
pathways
LUAD,
such
as
protein
translation
metabolic
pathways.
Interestingly,
all
enzymes
hexosamine
biosynthetic
pathway
(HBP)
found
be
upregulated,
suggesting
its
important
role
LUAD.
It
is
worthwhile
look
at
targeting
vulnerability
LUAD
new
strategy
drug
development.
All
MS
deposited
ProteomeXchange
identifier
PXD050598.